Węsierska-Gądek Józefa, Walzi Eva, Dolečkova Iva, Schmid Gerald
Cell Cycle Regulation Group, Div. Institute of Cancer Research, Dept. of Medicine I, Medical University of Vienna, Borschkegasse 8 a, Vienna, A-1090 Austria.
Cell Cycle Regulation Group, Div. Institute of Cancer Research, Dept. of Medicine I, Medical University of Vienna, Borschkegasse 8 a, Vienna, A-1090 Austria ; Christian Doppler Laboratory on Molecular Cancer Chemoprevention, Department of Medicine III, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, A-1090 Austria.
Cancer Microenviron. 2009 Sep 4;2(Suppl 1):215-25. doi: 10.1007/s12307-009-0024-9. eCollection 2009 Sep.
Overexpression of p53 tumor suppressor protein in malignant cells induces cell cycle arrest, or alternatively, apoptosis thereby indicating that additional factors may contribute to the p53-mediated outcome. Comparison of the experimental protocols revealed that the construct encoding wild-type (wt) p53 was expressed in cells of different origin. Therefore, we decided to determine whether the intrinsic cellular program of primary cells of the same genetic background could have any effect on the oncogenic potential of mutated c-Ha-RAS and TP53. Primary rat cells (RECs) isolated from rat embryos of different age: at 13.5 gd (y) and 15.5 gd (o), were used for transfection. Immortalized rat cell clones overexpressing temperature-sensitive (ts) p53(135val) mutant and transformed cell clones after co-transfection with oncogenic c-Ha-Ras, were generated. The ts p53(135Val) mutant, switching between wt and mutant conformation, offers the possibility to study the role of p53 in cell cycle control in a model of malignant transformation in cells with the same genetic background. Surprisingly, the kinetics of cell proliferation at non-permissive temperature and that of cell cycle arrest at 32°C strongly differed between cell clones established from yRECs and oRECs. Furthermore, the kinetics of the re-enter of G1-arrested cells in the active cell cycle strongly differed between distinct cell clones. Finally, the susceptibility of immortalized and transformed cells to the pharmacological inhibitors of cyclin-dependent kinases (CDKs) considerably differed. Our results clearly show that overexpression of genes such as mutated TP53 and oncogenic c-Ha-RAS is not able to fully override the intrinsic cellular programme.
恶性细胞中p53肿瘤抑制蛋白的过表达会诱导细胞周期停滞,或者诱导细胞凋亡,这表明可能有其他因素促成了p53介导的结果。对实验方案的比较显示,编码野生型(wt)p53的构建体在不同来源的细胞中均有表达。因此,我们决定确定具有相同遗传背景的原代细胞的内在细胞程序是否会对突变的c-Ha-RAS和TP53的致癌潜力产生影响。从不同年龄的大鼠胚胎(13.5天龄(y)和15.5天龄(o))分离得到的原代大鼠细胞(RECs)用于转染。通过共转染致癌性c-Ha-Ras,生成了过表达温度敏感型(ts)p53(135val)突变体的永生化大鼠细胞克隆和转化细胞克隆。ts p53(135Val)突变体在wt构象和突变构象之间切换,为在具有相同遗传背景的细胞恶性转化模型中研究p53在细胞周期调控中的作用提供了可能性。令人惊讶的是,从yRECs和oRECs建立的细胞克隆在非允许温度下的细胞增殖动力学以及在32°C时的细胞周期停滞动力学存在很大差异。此外,不同细胞克隆中G1期停滞细胞重新进入活跃细胞周期的动力学也存在很大差异。最后,永生化细胞和转化细胞对细胞周期蛋白依赖性激酶(CDK)的药理抑制剂的敏感性也有很大不同。我们的结果清楚地表明,诸如突变的TP53和致癌性c-Ha-RAS等基因的过表达不能完全超越内在的细胞程序。